These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 38053837)

  • 21. Cynomorium songaricum: UHPLC/ESI-LTQ-Orbitrap-MS analysis and mechanistic study on insulin sensitivity of a flavonoid-enriched fraction.
    Liu Z; Shang Q; Zuo H; Li H; Fang D; Zhang J; Huang HD; Granato D; Chen J; Chen J
    Phytomedicine; 2024 Sep; 132():155862. PubMed ID: 39032280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Linking Gut Microbiota and Inflammation to Obesity and Insulin Resistance.
    Saad MJ; Santos A; Prada PO
    Physiology (Bethesda); 2016 Jul; 31(4):283-93. PubMed ID: 27252163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic syndrome's new therapy: Supplement the gut microbiome.
    Xu YW; Tian J; Song Y; Zhang BC; Wang J
    World J Diabetes; 2024 Apr; 15(4):793-796. PubMed ID: 38680700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gut microbiome of a porcine model of metabolic syndrome and HF-pEF.
    O'Donovan AN; Herisson FM; Fouhy F; Ryan PM; Whelan D; Johnson CN; Cluzel G; Ross RP; Stanton C; Caplice NM
    Am J Physiol Heart Circ Physiol; 2020 Mar; 318(3):H590-H603. PubMed ID: 32031871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phytochemicals, Herbal Extracts, and Dietary Supplements for Metabolic Disease Management.
    Halagali P; Inamdar A; Singh J; Anand A; Sadhu P; Pathak R; Sharma H; Biswas D
    Endocr Metab Immune Disord Drug Targets; 2024 Apr; ():. PubMed ID: 38676520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanism and Application of Metabolomics.
    He X; Ji G; Jia W; Li H
    Int J Mol Sci; 2016 Mar; 17(3):300. PubMed ID: 26999104
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Huang HC; Chen CJ; Lai YH; Lin YC; Chiou WC; Lu HF; Chen YF; Chen YH; Huang C
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33808007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gut microbiota dysbiosis -associated obesity and its involvement in cardiovascular diseases and type 2 diabetes. A systematic review.
    Hamjane N; Mechita MB; Nourouti NG; Barakat A
    Microvasc Res; 2024 Jan; 151():104601. PubMed ID: 37690507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of HIIT and MICT and further detraining on metabolic syndrome and asprosin signaling pathway in metabolic syndrome model of rats.
    Rahim HA; Damirchi A; Babaei P
    Sci Rep; 2024 May; 14(1):11313. PubMed ID: 38760452
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Lee HA; Cho JH; Afinanisa Q; An GH; Han JG; Kang HJ; Choi SH; Seong HA
    Nutrients; 2020 Oct; 12(11):. PubMed ID: 33142995
    [No Abstract]   [Full Text] [Related]  

  • 31. G protein-coupled estrogen receptor 1 ameliorates nonalcoholic steatohepatitis through targeting AMPK-dependent signaling.
    Li L; Yao Y; Wang Y; Cao J; Jiang Z; Yang Y; Wang H; Ma H
    J Biol Chem; 2024 Mar; 300(3):105661. PubMed ID: 38246352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pinusolide improves high glucose-induced insulin resistance via activation of AMP-activated protein kinase.
    Hwang SL; Jeong YT; Hye Yang J; Li X; Lu Y; Son JK; Chang HW
    Biochem Biophys Res Commun; 2013 Aug; 437(3):374-9. PubMed ID: 23831466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Artemisia scoparia extract attenuates non-alcoholic fatty liver disease in diet-induced obesity mice by enhancing hepatic insulin and AMPK signaling independently of FGF21 pathway.
    Wang ZQ; Zhang XH; Yu Y; Tipton RC; Raskin I; Ribnicky D; Johnson W; Cefalu WT
    Metabolism; 2013 Sep; 62(9):1239-49. PubMed ID: 23702383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Salidroside and Curcumin Formula Prevents Liver Injury in Nonalcoholic Fatty Liver Disease in Rats.
    Li HS
    Ann Hepatol; 2018 Aug; 17(5):769-778. PubMed ID: 30145577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Links between oral microbiome and insulin resistance: Involvement of MAP kinase signaling pathway.
    Chang YR; Cheng WC; Hsiao YC; Su GW; Lin SJ; Wei YS; Chou HC; Lin HP; Lin GY; Chan HL
    Biochimie; 2023 Nov; 214(Pt B):134-144. PubMed ID: 37442534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AMP-activated protein kinase, fatty acid metabolism, and insulin sensitivity.
    Smith BK; Steinberg GR
    Curr Opin Clin Nutr Metab Care; 2017 Jul; 20(4):248-253. PubMed ID: 28375880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.
    Palomer X; Salvadó L; Barroso E; Vázquez-Carrera M
    Int J Cardiol; 2013 Oct; 168(4):3160-72. PubMed ID: 23932046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of the mTORC1/STAT3/Notch1 pathway by activated AMPK prevents hepatic insulin resistance induced by excess amino acids.
    Li H; Lee J; He C; Zou MH; Xie Z
    Am J Physiol Endocrinol Metab; 2014 Jan; 306(2):E197-209. PubMed ID: 24302004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genistein stimulates insulin sensitivity through gut microbiota reshaping and skeletal muscle AMPK activation in obese subjects.
    Guevara-Cruz M; Godinez-Salas ET; Sanchez-Tapia M; Torres-Villalobos G; Pichardo-Ontiveros E; Guizar-Heredia R; Arteaga-Sanchez L; Gamba G; Mojica-Espinosa R; Schcolnik-Cabrera A; Granados O; López-Barradas A; Vargas-Castillo A; Torre-Villalvazo I; Noriega LG; Torres N; Tovar AR
    BMJ Open Diabetes Res Care; 2020 Mar; 8(1):. PubMed ID: 32152146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.